Loading clinical trials...
Loading clinical trials...
Hyperlipidaemia especially elevation of low-density lipoprotein cholesterol (LDL-C) is known to be the main contributor to the development of atherosclerotic cardiovascular disease (ASCVD). Lowering ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chinese University of Hong Kong
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07512830 · Cardio Vascular Disease
NCT06062394 · Hypertension, Hyperlipidemias
NCT07432828 · Sleep Disorder (Disorder), Cardio Vascular Disease
NCT07379970 · Fitness Trackers, Cardio Vascular Disease, and more
Prince of Wales Hospital
Shatin, New Terrritories
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions